IMAT - ultrafast tomography for coronary artery disease Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: art slott who wrote (2635)	7/23/1998 10:04:00 AM
From: Bruce Rozenblit	Read Replies (1) of 3725

Hip Hip Hurrah! My Heartburn over HeartScan is over! This is tremendous news. Everybody wins. We get the cash, they take over the payments. The losses disappear. Lifetest becomes a client that will buy more machines. Imatron can divert all that manpower and money that was being sucked up by HeartScan into selling machines. GE is on board to market. The situation has gone from abysmal one year ago to very positive. Lifetest has an existing patient base and doctor network. That's what it take for this to work. HeartScan did not and was competing against the system. This is a good match for both firms. Accuimage is also on board for virtual everything. We still have work to do. Two major roadblocks. The insurance companies have to get on board and we can help by pounding on the government. Insurance companies were forced to pay for mammograms through legislation. The second is that a lot of Doc's think the machine is worthless. Imatron has to address that issue. It's hard to get some people to listen.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next